In this 149th episode, I do a deep-dive into autoimmunity, laboratory testing, food sensitivity, chemical sensitivity, and all things immunology
Metabolic alkalosis: a new red flag in status epilepticus
Eligible patients may qualify for free Rybelsus through the NovoCare Patient Assistance Program (PAP)
the plot of cellular mortality is shown in Fig
and reports other support from Travere Therapeutics Inc, the Doris Duke Charitable Foundation, Bayer AG, AstraZeneca, Novo Nordisk, The George Institute for Global Health, CareDx and KBP BioSciences, and personal fees from Boehringer Ingelheim, Bayer Pharmaceuticals and Eli Lilly